Progression of Myopic Maculopathy after Treatment of Choroidal Neovascularization | Zendy

Cláudia Farinha | Zendy; Alda S. Baltar | Zendy; Sandriunes | Zendy; João Figueira | Zendy; Isabel Pires | Zendy; Maria Luz Cachulo | Zendy; Rufino Silva | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Progression of Myopic Maculopathy after Treatment of Choroidal Neovascularization

Author(s) -

Cláudia Farinha,

Alda S. Baltar,

Sandriunes,

João Figueira,

Isabel Pires,

Maria Luz Cachulo,

Rufino Silva

Publication year - 2014

Publication title -

ophthalmologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.639

H-Index - 60

eISSN - 1423-0267

pISSN - 0030-3755

DOI - 10.1159/000357290

Subject(s) - choroidal neovascularization , medicine , ophthalmology , maculopathy , visual acuity , ranibizumab , fundus photography , macular degeneration , atrophy , fundus (uterus) , retinopathy , fluorescein angiography , surgery , bevacizumab , chemotherapy , diabetes mellitus , endocrinology

To evaluate the long-term progression of myopic maculopathy and functional outcome after treatment of myopic choroidal neovascularization (CNV) with photodynamic therapy (PDT) and/or intravitreal ranibizumab (IVR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research